Concepedia

G.S. Falchook

GF

2

Publications

73

Citations

2

H-Index

2022

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hackensack University Medical Center

Daiichi Sankyo (United States)

Dana-Farber Cancer Institute

National Cancer Center Hospital East

G.S. Falchook is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cancer therapeutics.

Top concepts

Publications per year

2022–2023

2

Publications

2

OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study

Melissa L. Johnson, Mark M. Awad, T. Koyama et al. · Journal of Thoracic Oncology · 2023 · 39 citations · Full text

, , +4

453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study

T. Doi, Minesh Patel, G.S. Falchook et al. · Annals of Oncology · 2022 · 34 citations

, , +7

Rows per page

1–2 of 2